CEPI FA2 Exploratory Award
Funds organizations designing and early-stage testing of new vaccine candidates against CEPI priority pathogens and Disease X viral families, with awards up to $1M over 18 months.
CEPI (Coalition for Epidemic Preparedness Innovations), a non-profit international association headquartered in Oslo, administers the Exploratory Award under its Innovations to Prepare for Future Epidemics and Pandemics call — Focus Area 2. The award is a grant of up to US $1 million over a maximum of 18 months, with no stated minimum and no cost-share requirement. CEPI funds all eligible costs di…
Vaccine candidate design and early-stage testing for CEPI priority pathogens: Lassa Fever, Disease X exemplar vaccines across paramyxoviruses, arenaviruses, coronaviruses (non-ACE-2 binding Sarbecoviruses), phenuiviruses, and nairoviruses. Covers immunogen design, candidate characterization studies, and immunogenicity studies.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Sign up free to see where teams trip up